• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡咯烷和吡唑啉酮衍生物作为锥虫磷酸二酯酶B1(TbrPDEB1)抑制剂的评价

Evaluation of pyrrolidine and pyrazolone derivatives as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).

作者信息

Amata Emanuele, Bland Nicholas D, Campbell Robert K, Pollastri Michael P

机构信息

Northeastern University Department of Chemistry and Chemical Biology, 417 Egan Research Center, 360 Huntington Avenue, Boston, MA 02115, USA.

Marine Biological Laboratory, Josephine Bay Paul Center for Comparative Molecular Biology and Evolution, 7 MBL Street, Woods Hole, MA 02543, USA.

出版信息

Tetrahedron Lett. 2015 May 20;56(21):2832-2835. doi: 10.1016/j.tetlet.2015.04.061.

DOI:10.1016/j.tetlet.2015.04.061
PMID:25977593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4426996/
Abstract

Human African trypanosomiasis (HAT) is a parasitic disease, caused by the protozoan pathogen , which affects thousands every year and which is in need of new therapeutics. Herein we report the synthesis and assessment of a series of pyrrolidine and pyrazolone derivatives of human phosphodiesterase 4 (hPDE4) inhibitors for the assessment of their activity against the trypanosomal phosphodiesterase TbrPDEB1. The synthesized compounds showed weak potency against TbrPDEB1.

摘要

人类非洲锥虫病(HAT)是一种由原生动物病原体引起的寄生虫病,每年影响数千人,并且需要新的治疗方法。在此,我们报告了一系列人磷酸二酯酶4(hPDE4)抑制剂的吡咯烷和吡唑啉酮衍生物的合成与评估,以评估它们对锥虫磷酸二酯酶TbrPDEB1的活性。合成的化合物对TbrPDEB1显示出较弱的效力。

相似文献

1
Evaluation of pyrrolidine and pyrazolone derivatives as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).吡咯烷和吡唑啉酮衍生物作为锥虫磷酸二酯酶B1(TbrPDEB1)抑制剂的评价
Tetrahedron Lett. 2015 May 20;56(21):2832-2835. doi: 10.1016/j.tetlet.2015.04.061.
2
Synthesis and assessment of catechol diether compounds as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).合成和评估儿茶素二醚类化合物作为原虫磷酸二酯酶 B1(TbrPDEB1)的抑制剂。
Bioorg Med Chem Lett. 2013 Nov 1;23(21):5971-4. doi: 10.1016/j.bmcl.2013.08.057. Epub 2013 Aug 21.
3
Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals.苯基哒嗪酮NPD - 001类似物作为有效的锥虫TbrPDEB1磷酸二酯酶抑制剂和体外杀锥虫剂的合成与评价
Bioorg Med Chem. 2016 Apr 1;24(7):1573-81. doi: 10.1016/j.bmc.2016.02.032. Epub 2016 Feb 26.
4
Repurposing human PDE4 inhibitors for neglected tropical diseases: design, synthesis and evaluation of cilomilast analogues as Trypanosoma brucei PDEB1 inhibitors.将人类磷酸二酯酶4(PDE4)抑制剂用于治疗被忽视的热带病:西洛司特类似物作为布氏锥虫PDEB1抑制剂的设计、合成与评估
Bioorg Med Chem Lett. 2014 Sep 1;24(17):4084-9. doi: 10.1016/j.bmcl.2014.07.063. Epub 2014 Jul 30.
5
Exploring the Activity Profile of TbrPDEB1 and hPDE4 Inhibitors Using Free Energy Perturbation.利用自由能微扰探索TbrPDEB1和hPDE4抑制剂的活性概况。
ACS Med Chem Lett. 2022 May 23;13(6):904-910. doi: 10.1021/acsmedchemlett.1c00690. eCollection 2022 Jun 9.
6
Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2).炔酰胺萘并[2,1-d]哒嗪酮类作为 TbrPDEB1 抑制剂的新类别(第 2 部分)。
Bioorg Med Chem. 2019 Sep 15;27(18):4013-4029. doi: 10.1016/j.bmc.2019.06.026. Epub 2019 Jul 5.
7
Repurposing human PDE4 inhibitors for neglected tropical diseases. Evaluation of analogs of the human PDE4 inhibitor GSK-256066 as inhibitors of PDEB1 of Trypanosoma brucei.将人类磷酸二酯酶4(PDE4)抑制剂用于治疗被忽视的热带病。评估人类PDE4抑制剂GSK - 256066的类似物作为布氏锥虫PDEB1抑制剂的活性。
Chem Biol Drug Des. 2015 May;85(5):549-64. doi: 10.1111/cbdd.12443. Epub 2014 Nov 18.
8
Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors.作为一类新型的 TbrPDEB1 抑制剂的炔酰胺酞嗪酮。
Bioorg Med Chem. 2019 Sep 15;27(18):3998-4012. doi: 10.1016/j.bmc.2019.06.027. Epub 2019 Jun 18.
9
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity.靶向布氏锥虫磷酸二酯酶 B1(TbrPDEB1)的亚口袋,使基于结构的发现具有杀变形虫活性的选择性抑制剂成为可能。
J Med Chem. 2018 May 10;61(9):3870-3888. doi: 10.1021/acs.jmedchem.7b01670. Epub 2018 May 1.
10
Discovery of novel Trypanosoma brucei phosphodiesterase B1 inhibitors by virtual screening against the unliganded TbrPDEB1 crystal structure.通过针对无配体 TbrPDEB1 晶体结构的虚拟筛选发现新型布氏锥虫磷酸二酯酶 B1 抑制剂。
J Med Chem. 2013 Mar 14;56(5):2087-96. doi: 10.1021/jm3017877. Epub 2013 Mar 1.

引用本文的文献

1
Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male mice.鉴定免疫抑制雄性感染微小隐孢子虫小鼠中有效的磷酸二酯酶抑制剂。
Nat Commun. 2024 Sep 27;15(1):8272. doi: 10.1038/s41467-024-52658-y.
2
Synthesis of new Spiropyrazole derivatives under microwaves irradiation and docking study for inhibition the microbes and COVID-19.微波辐射下新型螺吡唑衍生物的合成及其对微生物和新冠病毒抑制作用的对接研究
J Mol Struct. 2022 Dec 5;1269:133581. doi: 10.1016/j.molstruc.2022.133581. Epub 2022 Jun 25.
3
Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect.吡唑酮结构母核在药物化学中的研究进展与展望。
Eur J Med Chem. 2020 Jan 15;186:111893. doi: 10.1016/j.ejmech.2019.111893. Epub 2019 Nov 16.
4
Synthesis of diN-Substituted Glycyl-Phenylalanine Derivatives by Using Ugi Four Component Reaction and Their Potential as Acetylcholinesterase Inhibitors.通过 Ugi 四组分反应合成二取代甘氨酰苯丙氨酸衍生物及其作为乙酰胆碱酯酶抑制剂的潜力。
Molecules. 2019 Jan 6;24(1):189. doi: 10.3390/molecules24010189.
5
The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!锥虫中cAMP信号传导这一不断展开的故事:差异万岁!
Front Pharmacol. 2015 Sep 7;6:185. doi: 10.3389/fphar.2015.00185. eCollection 2015.

本文引用的文献

1
Repurposing human PDE4 inhibitors for neglected tropical diseases: design, synthesis and evaluation of cilomilast analogues as Trypanosoma brucei PDEB1 inhibitors.将人类磷酸二酯酶4(PDE4)抑制剂用于治疗被忽视的热带病:西洛司特类似物作为布氏锥虫PDEB1抑制剂的设计、合成与评估
Bioorg Med Chem Lett. 2014 Sep 1;24(17):4084-9. doi: 10.1016/j.bmcl.2014.07.063. Epub 2014 Jul 30.
2
Synthesis and assessment of catechol diether compounds as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).合成和评估儿茶素二醚类化合物作为原虫磷酸二酯酶 B1(TbrPDEB1)的抑制剂。
Bioorg Med Chem Lett. 2013 Nov 1;23(21):5971-4. doi: 10.1016/j.bmcl.2013.08.057. Epub 2013 Aug 21.
3
A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis.当前对治疗人类非洲锥虫病的化疗策略的分析。
Pathog Glob Health. 2013 Jul;107(5):242-52. doi: 10.1179/2047773213Y.0000000105.
4
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor response.优化类选择性组蛋白去乙酰化酶抑制剂的药代动力学,鉴定与肝癌肿瘤应答相关的候选预测性生物标志物。
J Med Chem. 2012 Oct 25;55(20):8903-25. doi: 10.1021/jm3011838. Epub 2012 Oct 12.
5
Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1.儿茶酚吡唑啉酮类化合物作为抗锥虫药物:基于片段的设计、合成及对锥虫磷酸二酯酶 B1 的纳摩尔抑制剂的药理学评价。
J Med Chem. 2012 Oct 25;55(20):8745-56. doi: 10.1021/jm301059b. Epub 2012 Oct 8.
6
Pharmacological validation of Trypanosoma brucei phosphodiesterases as novel drug targets.布鲁氏锥虫磷酸二酯酶的药理学验证作为新的药物靶点。
J Infect Dis. 2012 Jul 15;206(2):229-37. doi: 10.1093/infdis/jir857. Epub 2012 Jan 30.
7
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.布鲁氏锥虫磷酸二酯酶 B1 和 B2 的药理学验证作为治疗非洲昏睡病的可用药靶标。
J Med Chem. 2011 Dec 8;54(23):8188-94. doi: 10.1021/jm201148s. Epub 2011 Nov 8.
8
Target repurposing for neglected diseases.针对被忽视疾病的药物重定位。
Future Med Chem. 2011 Aug;3(10):1307-15. doi: 10.4155/fmc.11.92.
9
Novel potent and selective σ ligands: evaluation of their agonist and antagonist properties.新型强效和选择性 σ 配体:评估其激动剂和拮抗剂特性。
J Med Chem. 2011 May 26;54(10):3669-73. doi: 10.1021/jm200144j. Epub 2011 Apr 21.
10
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.硝呋替莫-依氟鸟氨酸联合疗法治疗第二阶段冈比亚布氏锥虫病:一项多中心、随机、III期、非劣效性试验
Lancet. 2009 Jul 4;374(9683):56-64. doi: 10.1016/S0140-6736(09)61117-X. Epub 2009 Jun 24.